Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
7,230,838
-
Total 13F shares
-
1,803,350
-
Share change
-
-283,443
-
Total reported value
-
$13,921,685
-
Price per share
-
$7.72
-
Number of holders
-
32
-
Value change
-
-$1,938,164
-
Number of buys
-
9
-
Number of sells
-
14
Institutional Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q2 2025
As of 30 Jun 2025 Atara Biotherapeutics, Inc. - Common Stock (ATRA) had 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,803,350 shares of stock of the company.
Largest 10 holders included EcoR1 Capital, LLC, Redmile Group, LLC, VANGUARD GROUP INC, Vestal Point Capital, LP, STALEY CAPITAL ADVISERS INC, BlackRock, Inc., ACADIAN ASSET MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, MARSHALL WACE, LLP, and STATE STREET CORP.
This table shows 32 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.